About us
Who We Are
Daimedex GmbH is a modern Contract Discovery and Research organisation (CDRO) where we combine experimental science and curated data to support drug discovery and development.
We are a spinout of Fraunhofer ITMP, developed in collaboration with Evolvus. Our foundation in the ProxiDrugs consortium, together with Evolvus’ manually curated datasets, allows us to approach discovery with both biological depth and data integrity.
Our team of biologists, clinicians, and data scientists focuses on one goal: turning complex biology into knowledge that advances new medicines. We combine experimental platforms, analytical tools, and expertise in biology and chemistry to support drug research from early discovery through clinical development.
We are more than a CDRO— we are a partner in progress, committed to shaping the future of medicine through discovery, development, and delivery of solutions that matter.
Find us
Our Research Headquarters
At Daimedex GmbH, science knows no boundaries — and neither do we. Our teams work across regions to stay close to our partners, collaborators, and clients. Whether you’re based in North America, Europe, or Asia-Pacific, you’ll find Daimedex GmbHexperts ready to support your journey from discovery to development.
Hamburg, Germany
Schnackenburgallee 114
22525 Hamburg, Germany
Pune India
Nanded City, Sinhgad Road,
Pune, Maharashtra – 411068
Germany
VolksparkLabs
Schnackenburgallee 114
22525 Hamburg, Germany
India
Symphony IT Park,
Nanded City, Sinhgad Road,
Pune, Maharashtra – 411068
General Inquiries: info@daimedex.com | Services & Partnerships: partnerships@daimedex.com
© 2025 Daimedex Disclaimer – A copyright disclaimer informs your site users that the site’s content — text, images, and video — are subject to copyright protection. In addition, you can state the rules guiding the use of your content. On the other hand, if you use any copyrighted content on your website without permission, identify it clearly, and include that you’re using it lawfully under the principle of fair use.